about
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...
Read More
1.14
-0.01
(-0.87%)
30,128
XNAS Volume
XNAS 03 Sep, 2025 11:00 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Boundless Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..